106 related articles for article (PubMed ID: 29723151)
1. [The effect of antipsychotic drug on monoamine receptors in peripheral blood mononuclear cells: affinity linked mechanism].
Taraskina AE; Zabotina AM; Nasyrova RF; Sosin DN; Sosina KA; Ershov EE; Grunina MN; Krupitsky EM
Biomed Khim; 2018 Mar; 64(2):201-207. PubMed ID: 29723151
[TBL] [Abstract][Full Text] [Related]
2. Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines.
Taraskina AE; Nasyrova RF; Zabotina AM; Sosin DN; Sosina КА; Ershov EE; Grunina MN; Krupitsky EM
BMC Psychiatry; 2017 Dec; 17(1):394. PubMed ID: 29221470
[TBL] [Abstract][Full Text] [Related]
3. The affinity of antipsychotic drugs to dopamine and serotonin 5-HT
Tollens F; Gass N; Becker R; Schwarz AJ; Risterucci C; Künnecke B; Lebhardt P; Reinwald J; Sack M; Weber-Fahr W; Meyer-Lindenberg A; Sartorius A
Eur Neuropsychopharmacol; 2018 Sep; 28(9):1035-1046. PubMed ID: 30006253
[TBL] [Abstract][Full Text] [Related]
4. Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells.
Stapel B; Sieve I; Falk CS; Bleich S; Hilfiker-Kleiner D; Kahl KG
J Psychiatr Res; 2018 Oct; 105():95-102. PubMed ID: 30216787
[TBL] [Abstract][Full Text] [Related]
5. 5-HT2 receptors modulate the expression of antipsychotic-induced dopamine supersensitivity.
Charron A; Hage CE; Servonnet A; Samaha AN
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2381-93. PubMed ID: 26508706
[TBL] [Abstract][Full Text] [Related]
6. Expression changes of serotonin receptor gene subtype 5HT3a in peripheral blood mononuclear cells from schizophrenic patients treated with haloperidol and Olanzapin.
Shariati GR; Ahangari G; Hossein-nezhad A; Asadi SM; Pooyafard F; Ahmadkhaniha HR
Iran J Allergy Asthma Immunol; 2009 Sep; 8(3):135-9. PubMed ID: 20124604
[TBL] [Abstract][Full Text] [Related]
7. Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.
Kessler RM; Ansari MS; Riccardi P; Li R; Jayathilake K; Dawant B; Meltzer HY
Neuropsychopharmacology; 2005 Dec; 30(12):2283-9. PubMed ID: 16123775
[TBL] [Abstract][Full Text] [Related]
8. Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia.
Paquet F; Soucy JP; Stip E; Lévesque M; Elie A; Bédard MA
J Neuropsychiatry Clin Neurosci; 2004; 16(1):47-56. PubMed ID: 14990759
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine: an updated review of its use in the management of schizophrenia.
Bhana N; Foster RH; Olney R; Plosker GL
Drugs; 2001; 61(1):111-61. PubMed ID: 11217867
[TBL] [Abstract][Full Text] [Related]
10. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
11. Dosing the antipsychotic medication olanzapine.
Nemeroff CB
J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication.
Kumarasinghe N; Beveridge NJ; Gardiner E; Scott RJ; Yasawardene S; Perera A; Mendis J; Suriyakumara K; Schall U; Tooney PA
Int J Neuropsychopharmacol; 2013 Aug; 16(7):1483-503. PubMed ID: 23442539
[TBL] [Abstract][Full Text] [Related]
13. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
[TBL] [Abstract][Full Text] [Related]
14. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
de Haan L; van Bruggen M; Lavalaye J; Booij J; Dingemans PM; Linszen D
Am J Psychiatry; 2003 Feb; 160(2):303-9. PubMed ID: 12562577
[TBL] [Abstract][Full Text] [Related]
15. Expression of Dopamine D
Wysokiński A; Kozłowska E; Szczepocka E; Łucka A; Agier J; Brzezińska-Błaszczyk E; Sobierajska K
Front Psychiatry; 2021; 12():645081. PubMed ID: 33776821
[No Abstract] [Full Text] [Related]
16. Antipsychotic drug effects on brain morphology in first-episode psychosis.
Lieberman JA; Tollefson GD; Charles C; Zipursky R; Sharma T; Kahn RS; Keefe RS; Green AI; Gur RE; McEvoy J; Perkins D; Hamer RM; Gu H; Tohen M;
Arch Gen Psychiatry; 2005 Apr; 62(4):361-70. PubMed ID: 15809403
[TBL] [Abstract][Full Text] [Related]
17. Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis.
Zipursky RB; Christensen BK; Daskalakis Z; Epstein I; Roy P; Furimsky I; Sanger T; Kapur S
Can J Psychiatry; 2005 Jul; 50(8):462-9. PubMed ID: 16127964
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin, beta-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controls.
Mauri MC; Rudelli R; Vanni S; Panza G; Sicaro A; Audisio D; Sacerdote P; Panerai AE
Psychiatry Res; 1998 Mar; 78(1-2):45-50. PubMed ID: 9579701
[TBL] [Abstract][Full Text] [Related]
20. Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways.
Sakai K; Gao XM; Hashimoto T; Tamminga CA
Synapse; 2001 Feb; 39(2):152-60. PubMed ID: 11180502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
